16449345

Source:http://linkedlifedata.com/resource/pubmed/id/16449345

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002006, umls-concept:C0035820, umls-concept:C0036536, umls-concept:C0036537, umls-concept:C0332120, umls-concept:C0681829, umls-concept:C1384514, umls-concept:C1533691, umls-concept:C1705480, umls-concept:C2587213
pubmed:issue	4
pubmed:dateCreated	2006-4-7
pubmed:abstractText	Arginine vasopressin (AVP) stimulates steroid secretion from the normal human adrenal gland and some cortisol-producing adrenocortical tumors or hyperplasia through activation of the V(1a) receptor.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0375362
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenocorticotropic Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone, http://linkedlifedata.com/resource/pubmed/chemical/Hormone Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasopressin, http://linkedlifedata.com/resource/pubmed/chemical/Vasopressins, http://linkedlifedata.com/resource/pubmed/chemical/relcovaptan
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0021-972X
pubmed:author	pubmed-author:DelarueCatherineC, pubmed-author:Do RegoJean-LucJL, pubmed-author:KuhnJean-MarcJM, pubmed-author:LefebvreHervéH, pubmed-author:PerraudinVéroniqueV, pubmed-author:VaudryHubertH
pubmed:issnType	Print
pubmed:volume	91
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1566-72
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16449345-Adenoma, pubmed-meshheading:16449345-Adrenocorticotropic Hormone, pubmed-meshheading:16449345-Aldosterone, pubmed-meshheading:16449345-Cross-Over Studies, pubmed-meshheading:16449345-Double-Blind Method, pubmed-meshheading:16449345-Female, pubmed-meshheading:16449345-Fluorescent Antibody Technique, pubmed-meshheading:16449345-Hormone Antagonists, pubmed-meshheading:16449345-Humans, pubmed-meshheading:16449345-Hyperaldosteronism, pubmed-meshheading:16449345-Immunohistochemistry, pubmed-meshheading:16449345-Indoles, pubmed-meshheading:16449345-Male, pubmed-meshheading:16449345-Middle Aged, pubmed-meshheading:16449345-Pituitary Neoplasms, pubmed-meshheading:16449345-Pyrrolidines, pubmed-meshheading:16449345-RNA, pubmed-meshheading:16449345-Receptors, Vasopressin, pubmed-meshheading:16449345-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16449345-Vasopressins
pubmed:year	2006
pubmed:articleTitle	Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies.
pubmed:affiliation	INSERM Unité 413, Laboratory of Cellular and Molecular Neuroendocrinology, European Institute for Peptide Research (Institut Fédératif de Recherche Multidisciplinaires sur les Peptides 23), University of Rouen, 76821 Mont-Saint-Aignan, France.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't